Analysts at Lifesci Capital issued their Q1 2025 EPS estimates for Zymeworks in a research note issued to investors on ...
LifeSci Capital analyst Charles Zhu initiated coverage with a Buy rating on Zymeworks (ZYME – Research Report) today and set a price target of ...
Despite posting disappointing top revenue and earnings misses for Q4 last week, Zymeworks (ZYME) has seen its shares rally over 5%, thanks in ...
Zacks Investment Research on MSN4d
Zymeworks (ZYME) Soars 5.4%: Is Further Upside Left in the Stock?Zymeworks Inc. (ZYME) shares soared 5.4% in the last trading session to close at $11.70. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares ...
Zymeworks Inc. ( NASDAQ:ZYME ) shareholders will have a reason to smile today, with the analysts making substantial... VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc ...
Zymeworks Inc (ZYME) navigates a challenging year with strategic pivots and robust partnership earnings, despite increased ...
Capital, LLC EcoR1, a director at $ZYME, bought 468,356 shares of the company on 03-13-2025 for an estimated $5,847,237. This trade was reported by Quiver ...
Investment analysts at HC Wainwright upped their Q1 2025 earnings per share estimates for Zymeworks in a note issued to investors on Monday, March 10th. HC Wainwright analyst R. Burns now anticipates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback